title: Development of a physiologically based pharmacokinetic model for decane, a constituent of jet propellent-8.
abstract: Decane, a 10-carbon n-alkane and one of the highest vapor phase constituents of jet propellent-8 (JP-8), was selected to represent the semivolatile fraction for the initial development of a physiologically based pharmacokinetic (PBPK) model for JP-8. Rats were exposed to decane vapors at time-weighted average concentrations of 1200, 781, or 273 ppm in a 32-L Leach chamber for 4 h. Time-course samples for 1200 ppm and end-of-exposure samples for 781 and 273 ppm decane exposures were collected from blood, brain, liver, fat, bone marrow, lung, skin, and spleen. The pharmacokinetics of decane could not be described by flow-limited assumptions and measured in vitro tissue/air partition coefficients. A refined PBPK model for decane was then developed using flow-limited (liver and lung) and diffusion-limited (brain, bone marrow, fat, skin, and spleen) equations to describe the uptake and clearance of decane in the blood and tissues. Partition coefficient values for blood/air and tissue/blood were estimated by fitting end-of-exposure pharmacokinetic data and assumed to reflect the available decane for rapid exchange with blood. A portion of decane is speculated to be sequestered in "deep" pools in the body, unavailable for rapid exchange with blood. PBPK model predictions were adequate in describing the tissues and blood kinetics. For model validation, the refined PBPK model for decane had mixed successes at predicting tissue and blood concentrations for lower concentrations of decane vapor, suggesting that further improvements in the model may be necessary to extrapolate to lower concentrations.
authors.affiliation: Department of Environmental Health Science, University of Georgia, Athens, Georgia 30602, USA.
authors.forename: U R
authors.initials: UR
authors.lastname: Perleberg
authors.forename: D A
authors.initials: DA
authors.lastname: Keys
authors.forename: J W
authors.initials: JW
authors.lastname: Fisher
mesh_terms: D000473:Alkanes / Q000008:administration & dosage / Q000737:chemistry / Q000493:pharmacokinetics*; D000818:Animals; D001273:Atmosphere Exposure Chambers; D001810:Blood Volume / Q000187:drug effects; D015824:Blood-Air Barrier; D002302:Cardiac Output / Q000187:drug effects; D002849:Chromatography, Gas; D003198:Computer Simulation; D006439:Hemodynamics / Q000187:drug effects; D019570:Inhalation Exposure; D008297:Male; D008954:Models, Biological; D051381:Rats; D011916:Rats, Inbred F344; D012039:Regional Blood Flow / Q000187:drug effects; D015203:Reproducibility of Results; D012129:Respiratory Function Tests; D014018:Tissue Distribution
chemical_list: D000473:Alkanes; C012867:decane